This inventor holds 1 USPTO granted patent. Top assignee: Prolifix Limited. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Guus Hateboer: Innovator in Adenovirus Research
Introduction
Guus Hateboer is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of virology, particularly in the study of adenoviruses. His work has implications for understanding viral mechanisms and potential therapeutic approaches.
Latest Patents
Guus Hateboer holds a patent for the invention titled "Adenovirus E1A-Associated protein BS69, inhibitor of E1A-transactivation." This patent represents his innovative approach to inhibiting viral transactivation, which could lead to advancements in antiviral therapies. He has 1 patent to his name.
Career Highlights
Hateboer is currently associated with Prolifix Limited, where he continues to explore the complexities of adenoviral interactions. His research is pivotal in developing strategies to combat adenoviral infections and enhance therapeutic efficacy.
Collaborations
One of his notable collaborators is Rene Bernards, with whom he has worked closely on various research projects. Their combined expertise has contributed to advancements in the understanding of adenoviral mechanisms.
Conclusion
Guus Hateboer is a prominent figure in adenovirus research, with a focus on innovative solutions to viral challenges. His contributions through patents and collaborations highlight his commitment to advancing the field of virology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile